CoChat

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

Open access
T., Vilsbøll, T., Krarup, S., Madsbad, J., Holst · 2002 · Diabetologia

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Aims/hypothesis Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type II (non-insulin-dependent) diabetes mellitus, whereas glucose-dependent insulinotropic polypeptide (GIP) is less effective. Our investigation evaluated "early" (protocol 1) - and "late phase" (protocol 2) insulin and C-peptide responses to GLP-1 and GIP stimulation in patients with Type II diabetes.Methods Protocol 1: eight Type II diabetic patients and eight matched healthy subjects received i.v. bolus injections of GLP-1(2.5 nmol) or GIP(7.5 nmol) concomitant with an increase of plasma glucose to 15 mmol/l. Protocol 2: eight Type II diabetic patients underwent a hyperglycaemic clamp (15 mmol/l) with infusion (per kg body weight/min) of either: 1 pmol GLP-1 (7-36) amide (n=8), 4 pmol GIP (n=8), 16 pmol GIP (n=4) or no incretin hormone (n=5). For comparison, six matched healthy subjects were examined.Results Protocol 1: Type II diabetic patients were characterised by a decreased "early phase" response to both stimuli, but their relative response to GIP versus GLP-1 stimulation was exactly the same as in healthy subjects [insulin (C-peptide): patients 59+/-9% (74+/-6%) and healthy subjects 62+/-5% (71+/-9%)]. Protocol 2, "Early phase" (0-20 min) insulin response to glucose was delayed and reduced in the patients, but enhanced slightly and similarly by GIP and GLP-1. GLP-1 augmented the "late phase" (20-120 min) insulin secretion to levels similar to those observed in healthy subjects. In contrast, the "late phase" responses to both doses of GIP were not different from those obtained with glucose alone. Accordingly, glucose infusion rates required to maintain the hyperglycaemic clamp in the "late phase" period (20-120 min) were similar with glucose alone and glucose plus GIP, whereas a doubling of the infusion rate was required during GLP-1 stimulation.Conclusion/interpretation Lack of GIP amplification of the late phase insulin response to glucose, which contrasts markedly to the normalising effect of GLP-1, could be a key defect in insulin secretion in Type II diabetic patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-002-0878-6

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Le Febvre (1991) Abnormal secretion of glucagon. In: Samuels E (ed) The endocrine pancreas. Raven Press, New York, pp 191-205

Cited by

See all 523

Metadata

Authors
T., V., T., K., S., M., & J., H.
Venue
Diabetologia
Published
2002-08-01
Volume
45
Issue
8
Pages
1111-1119
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2067710447
Cited by
518
References
36
Citations by year
2026: 9 · 2025: 17 · 2024: 20 · 2023: 13 · 2022: 19 · 2021: 16 · 2020: 22 · 2019: 33 · 2018: 24 · 2017: 22 · 2016: 22 · 2015: 23 · 2014: 21 · 2013: 25 · 2012: 25
FWCI
7.41
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
Funders
  • Novo Nordisk
  • Novo Nordisk Fonden
  • Diabetesforeningen
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, type 2 diabetes, obesity, first-phase insulin secretion, C-peptide, incretins, hyperglycaemic clamp, glucose infusion rate, beta-cell function, incretin resistance, GLP-1(7-36)amide
MeSH terms
Aged, Blood Glucose, C-Peptide, Diabetes Mellitus, Diabetes Mellitus, Type 2, Drug Synergism, Female, Glucagon, Glucose, Humans, Hypoglycemic Agents, Injections, Intravenous, Insulin, Male, Middle Aged, Obesity, Peptide Fragments, Protein Precursors, Reference Values, Time Factors, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. https://app.cochat.ai/papers/10.1007/s00125-002-0878-6
The paper
T., V., T., K., S., M., & J., H. (2002). Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia. https://doi.org/10.1007/s00125-002-0878-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.